Testosterone replacement in prostate cancer survivors with testosterone deficiency: study protocol of a randomized controlled trial (2022) Rodrigo J. Valderrábano, MD, MS; Karol Pencina, Ph.D.; Thomas W. Storer, Ph.D.; Kieran F. Reid Ph.D., MPH, Adam S. Kibel, MD, Arthur L. Burnett, MD; Grace Huang, MD, MS; Tanya Dorff, MD; Fabiola Privat, BS; Catherine Ghattas-Puylara, MPH; Lauren Wilson, RNP, Nancy K. Latham, Ph.D.; Mats Holmberg, MD Shalender Bhasin MB, BS
ABSTRACT
Background. Most men diagnosed with prostate cancer today have an organ-confined disease and a low...
Interview with Shalender Bhasin, MBBS, author of Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial, and Peter C. Albertsen, MD, author of Collaborating to Improve Quality of Life Among Prostate Cancer Survivors. Hosted by Eve Rittenberg, MD.
* over the past 4 decades he has become a global leader in the biology of androgens, sarcopenia and aging related functional decline, his research has shaped clinical guidelines, its informed public health policy particularly around testosterone therapy, anabolic interventions and then the development of function promoting therapies
Pay attention to 25:40-34:36 of the presentation where he explains the importance of measuring free testosterone using a standardized Equilibrium Dialysis method!
Explains the...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.